Bleomycin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bleomycin" in English language version.

refsWebsite

Global rank English rank

17nih.gov

4^th place

10doi.org

2^nd place

5web.archive.org

1^st place

2drugs.com

399^th place

333^rd place

2books.google.com

3^rd place

2semanticscholar.org

11^th place

8^th place

1fda.gov

447^th place

338^th place

1medicines.org.uk

3,823^rd place

2,387^th place

1europa.eu

68^th place

117^th place

1handle.net

102^nd place

76^th place

1anaesthesiawa.org

low place

1tulane.edu

5,659^th place

3,564^th place

1cancernetwork.com

low place

1harvard.edu

18^th place

17^th place

anaesthesiawa.org

Thompson M. "Bleomycin and Anaesthesia" (PDF). Anaesthesia Western Australia. Archived from the original (PDF) on 8 September 2017. Retrieved 8 September 2017.

books.google.com

Sneader W (2005). Drug discovery : a history (Rev. and updated ed.). Chichester: Wiley. p. 312. ISBN 9780471899792. Archived from the original on 5 March 2016.
Phillips GO (2018). Innovation and Technology Transfer in Japan and Europe: Industry-Academic Interactions. Routledge. p. PT155. ISBN 9780429774546.

cancernetwork.com

Takimoto CH, Calvo E (2008). "Principles of Oncologic Pharmacotherapy". In Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (eds.). Cancer Management: A Multidisciplinary Approach. Vol. 3 (11th ed.). UBM Medica LLC. Archived from the original on 15 May 2009.

doi.org

Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO (April 2020). "Interventions for the management of malignant pleural effusions: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2020 (4): CD010529. doi:10.1002/14651858.CD010529.pub3. PMC 7173736. PMID 32315458.
Shaw P, Agarwal R (2004). Shaw PH (ed.). "Pleurodesis for malignant pleural effusions". The Cochrane Database of Systematic Reviews (1): CD002916. doi:10.1002/14651858.CD002916.pub2. PMID 14973997. (Retracted, see doi:10.1002/14651858.CD002916.pub3, PMID 24259053)
Thomas R, Murray K, Lee YC (April 2018). "Treatment Approaches for Malignant Pleural Effusion". JAMA. 319 (14): 1507–1508. doi:10.1001/jama.2018.1323. PMID 29634827.
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R (September 2012). "Topical treatments for cutaneous warts". The Cochrane Database of Systematic Reviews. 9 (9): CD001781. doi:10.1002/14651858.CD001781.pub3. PMC 8101088. PMID 22972052.
Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H (December 2009). "Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice". American Journal of Respiratory Cell and Molecular Biology. 41 (6): 661–670. doi:10.1165/rcmb.2008-0182OC. PMC 10283344. PMID 19265174.
Ackerman BH, Kasbekar N (1997). "Disturbances of taste and smell induced by drugs". Pharmacotherapy. 17 (3): 482–496. doi:10.1002/j.1875-9114.1997.tb03058.x. PMID 9165552. S2CID 12671326.
Hecht SM (January 2000). "Bleomycin: new perspectives on the mechanism of action". Journal of Natural Products. 63 (1): 158–168. doi:10.1021/np990549f. PMID 10650103.
Hindra, Yang D, Teng Q, Dong LB, Crnovčić I, Huang T, et al. (March 2017). "Genome Mining of Streptomyces mobaraensis DSM40847 as a Bleomycin Producer Providing a Biotechnology Platform To Engineer Designer Bleomycin Analogues". Organic Letters. 19 (6): 1386–1389. doi:10.1021/acs.orglett.7b00283. PMID 28256838.
Yang D, Hindra, Dong LB, Crnovcic I, Shen B (August 2017). "Engineered production and evaluation of 6'-deoxy-tallysomycin H-1 revealing new insights into the structure-activity relationship of the anticancer drug bleomycin". The Journal of Antibiotics. 71: 97–103. doi:10.1038/ja.2017.93. PMID 28831149. S2CID 33531845.
Song N, Liu J, Shaheen S, Du L, Proctor M, Roman J, et al. (August 2015). "Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice". Scientific Reports. 5: 13419. Bibcode:2015NatSR...513419S. doi:10.1038/srep13419. PMC 4542162. PMID 26289670. In our studies, mice developed classic PF with structural alteration of the lung following intravenous bleomycin treatment

drugs.com

"Bleomycin Use During Pregnancy". Drugs.com. 9 August 2019. Retrieved 16 February 2020.
"Bleomycin Sulfate". The American Society of Health-System Pharmacists. Archived from the original on 8 September 2015. Retrieved 1 August 2015.

europa.eu

ema.europa.eu

"Bleomycin". European Medicines Agency (EMA). 18 March 2009.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

harvard.edu

ui.adsabs.harvard.edu

Song N, Liu J, Shaheen S, Du L, Proctor M, Roman J, et al. (August 2015). "Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice". Scientific Reports. 5: 13419. Bibcode:2015NatSR...513419S. doi:10.1038/srep13419. PMC 4542162. PMID 26289670. In our studies, mice developed classic PF with structural alteration of the lung following intravenous bleomycin treatment

medicines.org.uk

"Bleo-Kyowa Powder for solution for injection - Summary of Product Characteristics (SmPC)". (emc). 31 August 2018. Archived from the original on 16 February 2020. Retrieved 16 February 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO (April 2020). "Interventions for the management of malignant pleural effusions: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2020 (4): CD010529. doi:10.1002/14651858.CD010529.pub3. PMC 7173736. PMID 32315458.
Shaw P, Agarwal R (2004). Shaw PH (ed.). "Pleurodesis for malignant pleural effusions". The Cochrane Database of Systematic Reviews (1): CD002916. doi:10.1002/14651858.CD002916.pub2. PMID 14973997. (Retracted, see doi:10.1002/14651858.CD002916.pub3, PMID 24259053)
Thomas R, Murray K, Lee YC (April 2018). "Treatment Approaches for Malignant Pleural Effusion". JAMA. 319 (14): 1507–1508. doi:10.1001/jama.2018.1323. PMID 29634827.
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R (September 2012). "Topical treatments for cutaneous warts". The Cochrane Database of Systematic Reviews. 9 (9): CD001781. doi:10.1002/14651858.CD001781.pub3. PMC 8101088. PMID 22972052.
Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H (December 2009). "Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice". American Journal of Respiratory Cell and Molecular Biology. 41 (6): 661–670. doi:10.1165/rcmb.2008-0182OC. PMC 10283344. PMID 19265174.
Huls G, ten Bokkel Huinink D (February 2003). "Bleomycin and scuba diving: to dive or not to dive?". The Netherlands Journal of Medicine. 61 (2): 50–53. PMID 12735422.
Ackerman BH, Kasbekar N (1997). "Disturbances of taste and smell induced by drugs". Pharmacotherapy. 17 (3): 482–496. doi:10.1002/j.1875-9114.1997.tb03058.x. PMID 9165552. S2CID 12671326.
Hecht SM (January 2000). "Bleomycin: new perspectives on the mechanism of action". Journal of Natural Products. 63 (1): 158–168. doi:10.1021/np990549f. PMID 10650103.
Hindra, Yang D, Teng Q, Dong LB, Crnovčić I, Huang T, et al. (March 2017). "Genome Mining of Streptomyces mobaraensis DSM40847 as a Bleomycin Producer Providing a Biotechnology Platform To Engineer Designer Bleomycin Analogues". Organic Letters. 19 (6): 1386–1389. doi:10.1021/acs.orglett.7b00283. PMID 28256838.
Yang D, Hindra, Dong LB, Crnovcic I, Shen B (August 2017). "Engineered production and evaluation of 6'-deoxy-tallysomycin H-1 revealing new insights into the structure-activity relationship of the anticancer drug bleomycin". The Journal of Antibiotics. 71: 97–103. doi:10.1038/ja.2017.93. PMID 28831149. S2CID 33531845.
Umezawa H, Maeda K, Takeuchi T, Okami Y (September 1966). "New antibiotics, bleomycin A and B". The Journal of Antibiotics. 19 (5): 200–9. PMID 5953301.
Song N, Liu J, Shaheen S, Du L, Proctor M, Roman J, et al. (August 2015). "Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice". Scientific Reports. 5: 13419. Bibcode:2015NatSR...513419S. doi:10.1038/srep13419. PMC 4542162. PMID 26289670. In our studies, mice developed classic PF with structural alteration of the lung following intravenous bleomycin treatment

ncbi.nlm.nih.gov

Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO (April 2020). "Interventions for the management of malignant pleural effusions: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2020 (4): CD010529. doi:10.1002/14651858.CD010529.pub3. PMC 7173736. PMID 32315458.
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R (September 2012). "Topical treatments for cutaneous warts". The Cochrane Database of Systematic Reviews. 9 (9): CD001781. doi:10.1002/14651858.CD001781.pub3. PMC 8101088. PMID 22972052.
Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H (December 2009). "Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice". American Journal of Respiratory Cell and Molecular Biology. 41 (6): 661–670. doi:10.1165/rcmb.2008-0182OC. PMC 10283344. PMID 19265174.
Song N, Liu J, Shaheen S, Du L, Proctor M, Roman J, et al. (August 2015). "Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice". Scientific Reports. 5: 13419. Bibcode:2015NatSR...513419S. doi:10.1038/srep13419. PMC 4542162. PMID 26289670. In our studies, mice developed classic PF with structural alteration of the lung following intravenous bleomycin treatment

dailymed.nlm.nih.gov

"Bleomycin- bleomycin sulfate injection, powder, lyophilized, for solution". DailyMed. 31 December 2019. Retrieved 16 February 2020.

semanticscholar.org

api.semanticscholar.org

Ackerman BH, Kasbekar N (1997). "Disturbances of taste and smell induced by drugs". Pharmacotherapy. 17 (3): 482–496. doi:10.1002/j.1875-9114.1997.tb03058.x. PMID 9165552. S2CID 12671326.
Yang D, Hindra, Dong LB, Crnovcic I, Shen B (August 2017). "Engineered production and evaluation of 6'-deoxy-tallysomycin H-1 revealing new insights into the structure-activity relationship of the anticancer drug bleomycin". The Journal of Antibiotics. 71: 97–103. doi:10.1038/ja.2017.93. PMID 28831149. S2CID 33531845.

tulane.edu

tmedweb.tulane.edu

"bleomycin [TUSOM | Pharmwiki]". tmedweb.tulane.edu. Retrieved 2 February 2022.

web.archive.org

"Bleo-Kyowa Powder for solution for injection - Summary of Product Characteristics (SmPC)". (emc). 31 August 2018. Archived from the original on 16 February 2020. Retrieved 16 February 2020.
"Bleomycin Sulfate". The American Society of Health-System Pharmacists. Archived from the original on 8 September 2015. Retrieved 1 August 2015.
Sneader W (2005). Drug discovery : a history (Rev. and updated ed.). Chichester: Wiley. p. 312. ISBN 9780471899792. Archived from the original on 5 March 2016.
Thompson M. "Bleomycin and Anaesthesia" (PDF). Anaesthesia Western Australia. Archived from the original (PDF) on 8 September 2017. Retrieved 8 September 2017.
Takimoto CH, Calvo E (2008). "Principles of Oncologic Pharmacotherapy". In Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (eds.). Cancer Management: A Multidisciplinary Approach. Vol. 3 (11th ed.). UBM Medica LLC. Archived from the original on 15 May 2009.